Michael A. Kolodziej, MD


Grappling With the Fallout of Genetic Testing, in Oncology and Beyond

January 29, 2014

Moving beyond the topic, Companion Diagnostics in Targeted Treatment, the panel took on the unregulated nature of testing in the wake of the June 2013 US Supreme Court ruling against Myriad Genetics, which ended the company's BRCA testing monopoly.